Phillips, MR, Zhang, J, Shi, Q, Song, Z, Ding, Z, Pang, S, et al. Prevalence, treatment, and associated
disability of mental disorders in four provinces in China during 2001-05:
an epidemiological survey. Lancet
2009; 373: 2041–53.
Wilde, A, Mitchell, PB, Meiser, B, Schofield, PR. Implications of the use of genetic tests in
psychiatry, with a focus on major depressive disorder: a
review. Depress Anxiety
2013; 30: 267–75.
Arroyo, C, Hu, FB, Ryan, LM, Kawachi, I, Colditz, GA, Speizer, FE, et al. Depressive symptoms and risk of type 2
diabetes in women. Diabetes Care
2004; 27: 129–33.
Everson, SA, Goldberg, DE, Kaplan, GA, Julkunen, J, Salonen, JT. Anger expression and incident
hypertension. Psychosom Med
1998; 60: 730–5.
Ferketich, AK, Schwartzbaum, JA, Frid, DJ, Moeschberger, ML. Depression as an antecedent to heart disease among
women and men in the NHANES I study. Arch Intern
2000; 160: 1261–8.
Hepgul, N, Cattaneo, A, Zunszain, PA, Pariante, CM. Depression pathogenesis and treatment: what can we
learn from blood mRNA expression?
2013; 11: 28.
Raedler, TJ. Inflammatory mechanisms in major depressive
disorder. Curr Opin Psychiatry
2011; 24: 519–25.
Yi, Z, Li, Z, Yu, S, Yuan, C, Hong, W, Wang, Z, et al. Blood-based gene expression profiles models
for classification of subsyndromal symptomatic depression and major
depressive disorder. PLoS One
Maes, M, Delange, J, Ranjan, R, Meltzer, HY, Desnyder, R, Cooremans, W, et al. Acute phase proteins in schizophrenia, mania
and major depression: modulation by psychotropic drugs.
Inoue, H, Mashimo, Y, Funamizu, M, Shimojo, N, Hasegawa, K, Hirota, T, et al. Association study of the C3 gene with adult
and childhood asthma. J Hum Genet
2008; 53: 728–38.
Ripoche, J, Day, AJ, Harris, TJ, Sim, RB. The complete amino acid sequence of human complement
factor H. Biochem J
Gehrs, KM, Jackson, JR, Brown, EN, Allikmets, R, Hageman, GS. Complement, age-related macular degeneration and a
vision of the future. Arch Ophthalmol
2010; 128: 349–58.
Adams, MKM, Simpson, JA, Richardson, AJ, Guymer, RH, Williamson, E, Cantsilieris, S, et al. Can genetic associations change with age? CFH
and age-related macular degeneration. Human
2012; 21: 5229–36.
Yang, XB, Sun, JL, Gao, Y, Tan, AH, Zhang, HY, Hu, YL, et al. Genome-wide association study for serum
complement C3 and C4 levels in healthy Chinese subjects.
Baron, M. Manic-depression genes and the new millennium:
poised for discovery. Mol Psychiatry
2002; 7: 342–58.
Detera-Wadleigh, SD, Badner, JA, Berrettini, WH, Yoshikawa, T, Goldin, LR, Turner, G, et al. A high-density genome scan detects evidence
for a bipolar-disorder susceptibility locus on 13q32 and other potential
loci on 1q32 and 18p11.2. Proc Natl Acad Sci
1999; 96: 5604–9.
Yuan, DQ, Yang, Q, Liu, XY, Yuan, DL, Yuan, ST, Xie, P, et al. Complement factor H Val62Ile variant and risk
of age-related macular degeneration: a meta-analysis.
2013; 19: 374–83.
Jivraj, J, Jivraj, I, Tennant, M, Rudnisky, C. Prevalence and impact of depressive symptoms in
patients with age-related macular degeneration.
Can J Ophthalmol
2013; 48: 269–73.
Eramudugolla, R, Wood, J, Anstey, KJ. Co-morbidity of depression and anxiety in common
age-related eye diseases: a population-based study of 662
adults. Front Aging Neurosci
2013; 5: 56.
Hamilton, M. A rating scale for depression.
J Neurol Neurosurg Psychiatry
Li, Z, Zhang, C, Fan, J, Yuan, C, Huang, J, Chen, J, et al. Brain-derived neurotrophic factor levels and
bipolar disorder in patients in their first depressive episode: 3-year
prospective longitudinal study. Br J
Fang, Y, Yuan, C, Xu, Y, Chen, J, Wu, Z, Cao, L, et al. A pilot study of the efficacy and safety of
paroxetine augmented with risperidone, valproate, buspirone, trazodone,
or thyroid hormone in adult Chinese patients with treatment-resistant
major depression. J Clin Psychopharmacol
2011; 31: 638–42.
Fang, Y, Yuan, C, Xu, Y, Chen, J, Wu, Z, Cao, L, et al. Comparisons of the efficacy and tolerability
of extended-release venlafaxine, mirtazapine, and paroxetine in
treatment-resistant depression: a double-blind, randomized pilot study in
a Chinese population. J Clin
2010; 30: 357–64.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM–IV–TR Axis I
Disorders: Research Version, Patient Edition (SCID–I/P).
Biometrics Research, New York State Psychiatric
American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders (4th edn) (DSM-IV).
Zhang, DF, Wang, D, Li, YY, Yao, YG. Mapping genetic variants in the CFH gene for
association with leprosy in Han Chinese. Genes
2014; 15: 506–10.
Chen, H, Liu, K, Chen, LJ, Hou, P, Chen, W, Pang, CP. Genetic associations in polypoidal choroidal
vasculopathy: a systematic review and meta-analysis.
2012; 18: 816–29.
Huang, L, Li, Y, Guo, S, Sun, Y, Zhang, C, Bai, Y, et al. Different hereditary contribution of the CFH
Gene between polypoidal choroidal vasculopathy and age-related macular
degeneration in Chinese Han People. Invest
Ophthalmol Vis Sci
2014; 55: 2534–8.
Holland, MM, Parson, W. GeneMarker(R) HID: a reliable software tool for the
analysis of forensic STR data. J Forensic
Ramasamy, A, Trabzuni, D, Guelfi, S, Varghese, V, Smith, C, Walker, R, et al. Genetic variability in the regulation of gene
expression in ten regions of the human brain. Nat
2014; 17: 1418–28.
Ansari, M, McKeigue, PM, Skerka, C, Hayward, C, Rudan, I, Vitart, V, et al. Genetic influences on plasma CFH and CFHR1
concentrations and their role in susceptibility to age-related macular
degeneration. Hum Mol Genet
2013; 22: 4857–69.
Fanous, AH, Kendler, KS. Genetic heterogeneity, modifier genes, and
quantitative phenotypes in psychiatric illness: searching for a
framework. Mol Psychiatry
Power, RA, Keers, R, Ng, MY, Butler, AW, Uher, R, Cohen-Woods, S, et al. Dissecting the genetic heterogeneity of
depression through age at onset. Am J Med Genet
2012; 159B: 859–68.
Klein, RJ, Zeiss, C, Chew, EY, Tsai, JY, Sackler, RS, Haynes, C, et al. Complement factor H polymorphism in
age-related macular degeneration.
2005; 308: 385–9.
Rodriguez de Cordoba, S, Esparza-Gordillo, J, Goicoechea de Jorge, E, Lopez-Trascasa, M, Sanchez-Corral, P. The human complement factor H: functional roles,
genetic variations and disease associations. Mol
2004; 41: 355–67.
Chen, H, Yu, KD, Xu, GZ. Association between variant Y402H in age-related
macular degeneration (AMD) susceptibility gene CFH and treatment response
of AMD: a meta-analysis. PLoS One
Raychaudhuri, S, Iartchouk, O, Chin, K, Tan, PL, Tai, AK, Ripke, S, et al. A rare penetrant mutation in CFH confers high
risk of age-related macular degeneration. Nat
2011; 43: 1232–6.
Hasler, G, Northoff, G. Discovering imaging endophenotypes for major
depression. Mol Psychiatry
2011; 16: 604–19.
Jonsen, A, Nilsson, SC, Ahlqvist, E, Svenungsson, E, Gunnarsson, I, Eriksson, KG, et al. Mutations in genes encoding complement
inhibitors CD46 and CFH affect the age at nephritis onset in patients
with systemic lupus erythematosus. Arthritis Res
Noris, M, Caprioli, J, Bresin, E, Mossali, C, Pianetti, G, Gamba, S, et al. Relative role of genetic complement
abnormalities in sporadic and familial aHUS and their impact on clinical
phenotype. Clin J Am Soc Nephro
2010; 5: 1844–59.
Donoso, LA, Vrabec, T, Kuivaniemi, H. The role of complement factor H in age-related
macular degeneration: a review. Surv
2010; 55: 227–46.
Frank, MG, Frank, JLW, Hendricks, SE, Burke, WJ, Johnson, DR. Age at onset of major depressive disorder predicts
reductions in NK cell number and activity. J
2002; 71: 159–67.
Massat, I, Souery, D, Del-Favero, J, Nothen, M, Blackwood, D, Muir, W, et al. Association between COMT (Val158Met)
functional polymorphism and early onset in patients with major depressive
disorder in a European multicenter genetic association
study. Mol Psychiatry